1 not yet recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
Follow SKB315 for injection: new trials by email Literature Review of SKB315 for injection trials Research Report on SKB315 for injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SKB315 in Combination Therapy in Patients With Advanced or Metastatic GC/ GEJ Adenocarcinoma Tislelizumab, SKB315 for injection, Capecitabine - Gastroesophageal Junction Adenocarcinoma | Phase 2 | Not yet recruiting | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 80 | 2026-06-30 | 2026-05-27 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (1)
China (1)
Yi Ba, professor (1)